A detailed history of Palogic Value Management, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Palogic Value Management, L.P. holds 1,679 shares of JNJ stock, worth $269,126. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,679
Previous 1,679 -0.0%
Holding current value
$269,126
Previous $266 Million 7.6%
% of portfolio
0.1%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $15,435 - $16,611
-100 Reduced 5.62%
1,679 $278 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $284,995 - $319,846
1,779 New
1,779 $314 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Palogic Value Management, L.P. Portfolio

Follow Palogic Value Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palogic Value Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Palogic Value Management, L.P. with notifications on news.